nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—SLC6A2—Clonidine—glaucoma	0.0974	0.169	CbGbCtD
Tapentadol—CYP2D6—Carteolol—glaucoma	0.0789	0.137	CbGbCtD
Tapentadol—CYP2D6—Betaxolol—glaucoma	0.0533	0.0924	CbGbCtD
Tapentadol—CYP2C19—Methazolamide—glaucoma	0.0531	0.0921	CbGbCtD
Tapentadol—CYP2C9—Diclofenamide—glaucoma	0.0513	0.089	CbGbCtD
Tapentadol—CYP2C9—Dorzolamide—glaucoma	0.0496	0.0859	CbGbCtD
Tapentadol—CYP2C19—Timolol—glaucoma	0.0452	0.0783	CbGbCtD
Tapentadol—CYP2C9—Methazolamide—glaucoma	0.0442	0.0766	CbGbCtD
Tapentadol—CYP2D6—Methazolamide—glaucoma	0.0404	0.07	CbGbCtD
Tapentadol—CYP2D6—Timolol—glaucoma	0.0343	0.0595	CbGbCtD
Tapentadol—CYP2D6—Clonidine—glaucoma	0.0292	0.0506	CbGbCtD
Tapentadol—Hypotension—Pilocarpine—glaucoma	0.000364	0.00103	CcSEcCtD
Tapentadol—Paraesthesia—Brinzolamide—glaucoma	0.000364	0.00103	CcSEcCtD
Tapentadol—Dyspepsia—Dorzolamide—glaucoma	0.000363	0.00102	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Timolol—glaucoma	0.000361	0.00102	CcSEcCtD
Tapentadol—Dyspnoea—Brinzolamide—glaucoma	0.000361	0.00102	CcSEcCtD
Tapentadol—Dyspepsia—Travoprost—glaucoma	0.000361	0.00102	CcSEcCtD
Tapentadol—Asthenia—Apraclonidine—glaucoma	0.000361	0.00102	CcSEcCtD
Tapentadol—Somnolence—Brinzolamide—glaucoma	0.00036	0.00102	CcSEcCtD
Tapentadol—Vision blurred—Clonidine—glaucoma	0.000359	0.00101	CcSEcCtD
Tapentadol—Decreased appetite—Dorzolamide—glaucoma	0.000358	0.00101	CcSEcCtD
Tapentadol—Erectile dysfunction—Timolol—glaucoma	0.000358	0.00101	CcSEcCtD
Tapentadol—Urticaria—Acetazolamide—glaucoma	0.000357	0.00101	CcSEcCtD
Tapentadol—Tremor—Clonidine—glaucoma	0.000357	0.00101	CcSEcCtD
Tapentadol—Dyspepsia—Brinzolamide—glaucoma	0.000357	0.00101	CcSEcCtD
Tapentadol—Eye disorder—Betaxolol—glaucoma	0.000356	0.001	CcSEcCtD
Tapentadol—Pruritus—Apraclonidine—glaucoma	0.000355	0.001	CcSEcCtD
Tapentadol—Fatigue—Dorzolamide—glaucoma	0.000355	0.001	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000355	0.001	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Travoprost—glaucoma	0.000354	0.001	CcSEcCtD
Tapentadol—Fatigue—Travoprost—glaucoma	0.000354	0.000998	CcSEcCtD
Tapentadol—Cardiac disorder—Betaxolol—glaucoma	0.000354	0.000998	CcSEcCtD
Tapentadol—Insomnia—Pilocarpine—glaucoma	0.000352	0.000994	CcSEcCtD
Tapentadol—Decreased appetite—Brinzolamide—glaucoma	0.000352	0.000994	CcSEcCtD
Tapentadol—Weight decreased—Timolol—glaucoma	0.000352	0.000993	CcSEcCtD
Tapentadol—Constipation—Travoprost—glaucoma	0.000351	0.00099	CcSEcCtD
Tapentadol—Agitation—Clonidine—glaucoma	0.00035	0.000988	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00035	0.000987	CcSEcCtD
Tapentadol—Paraesthesia—Pilocarpine—glaucoma	0.00035	0.000987	CcSEcCtD
Tapentadol—Asthenia—Bimatoprost—glaucoma	0.00035	0.000987	CcSEcCtD
Tapentadol—Fatigue—Brinzolamide—glaucoma	0.000349	0.000986	CcSEcCtD
Tapentadol—Angioedema—Clonidine—glaucoma	0.000348	0.000982	CcSEcCtD
Tapentadol—Dyspnoea—Pilocarpine—glaucoma	0.000347	0.00098	CcSEcCtD
Tapentadol—Somnolence—Pilocarpine—glaucoma	0.000346	0.000977	CcSEcCtD
Tapentadol—Depression—Timolol—glaucoma	0.000346	0.000976	CcSEcCtD
Tapentadol—Angiopathy—Betaxolol—glaucoma	0.000346	0.000976	CcSEcCtD
Tapentadol—Pruritus—Bimatoprost—glaucoma	0.000345	0.000973	CcSEcCtD
Tapentadol—Immune system disorder—Betaxolol—glaucoma	0.000344	0.000971	CcSEcCtD
Tapentadol—Diarrhoea—Apraclonidine—glaucoma	0.000344	0.00097	CcSEcCtD
Tapentadol—Mediastinal disorder—Betaxolol—glaucoma	0.000343	0.000969	CcSEcCtD
Tapentadol—Dyspepsia—Pilocarpine—glaucoma	0.000343	0.000967	CcSEcCtD
Tapentadol—Chills—Betaxolol—glaucoma	0.000342	0.000965	CcSEcCtD
Tapentadol—Syncope—Clonidine—glaucoma	0.000342	0.000964	CcSEcCtD
Tapentadol—Feeling abnormal—Dorzolamide—glaucoma	0.000339	0.000958	CcSEcCtD
Tapentadol—Decreased appetite—Pilocarpine—glaucoma	0.000338	0.000955	CcSEcCtD
Tapentadol—Feeling abnormal—Travoprost—glaucoma	0.000338	0.000954	CcSEcCtD
Tapentadol—Palpitations—Clonidine—glaucoma	0.000337	0.00095	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000336	0.000949	CcSEcCtD
Tapentadol—Loss of consciousness—Clonidine—glaucoma	0.000335	0.000945	CcSEcCtD
Tapentadol—Feeling abnormal—Brinzolamide—glaucoma	0.000334	0.000942	CcSEcCtD
Tapentadol—Mental disorder—Betaxolol—glaucoma	0.000334	0.000942	CcSEcCtD
Tapentadol—Constipation—Pilocarpine—glaucoma	0.000333	0.00094	CcSEcCtD
Tapentadol—Cough—Clonidine—glaucoma	0.000332	0.000938	CcSEcCtD
Tapentadol—Dizziness—Apraclonidine—glaucoma	0.000332	0.000938	CcSEcCtD
Tapentadol—Malnutrition—Betaxolol—glaucoma	0.000332	0.000936	CcSEcCtD
Tapentadol—Urticaria—Dorzolamide—glaucoma	0.000327	0.000924	CcSEcCtD
Tapentadol—Tension—Betaxolol—glaucoma	0.000325	0.000919	CcSEcCtD
Tapentadol—Arthralgia—Clonidine—glaucoma	0.000324	0.000915	CcSEcCtD
Tapentadol—Anxiety—Clonidine—glaucoma	0.000323	0.000912	CcSEcCtD
Tapentadol—Asthenia—Acetazolamide—glaucoma	0.000322	0.00091	CcSEcCtD
Tapentadol—Dizziness—Bimatoprost—glaucoma	0.000322	0.000909	CcSEcCtD
Tapentadol—Nervousness—Betaxolol—glaucoma	0.000322	0.000909	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000322	0.000909	CcSEcCtD
Tapentadol—Urticaria—Brinzolamide—glaucoma	0.000322	0.000908	CcSEcCtD
Tapentadol—Feeling abnormal—Pilocarpine—glaucoma	0.000321	0.000906	CcSEcCtD
Tapentadol—Vomiting—Apraclonidine—glaucoma	0.000319	0.000902	CcSEcCtD
Tapentadol—Hypersensitivity—Brimonidine—glaucoma	0.000318	0.000897	CcSEcCtD
Tapentadol—Dry mouth—Clonidine—glaucoma	0.000317	0.000895	CcSEcCtD
Tapentadol—Bradycardia—Timolol—glaucoma	0.000317	0.000894	CcSEcCtD
Tapentadol—Dermatitis—Apraclonidine—glaucoma	0.000317	0.000893	CcSEcCtD
Tapentadol—Headache—Apraclonidine—glaucoma	0.000315	0.000889	CcSEcCtD
Tapentadol—Confusional state—Clonidine—glaucoma	0.000313	0.000885	CcSEcCtD
Tapentadol—Vision blurred—Betaxolol—glaucoma	0.000313	0.000882	CcSEcCtD
Tapentadol—Oedema—Clonidine—glaucoma	0.000311	0.000878	CcSEcCtD
Tapentadol—Tremor—Betaxolol—glaucoma	0.000311	0.000877	CcSEcCtD
Tapentadol—Hallucination—Timolol—glaucoma	0.00031	0.000874	CcSEcCtD
Tapentadol—Asthenia—Brimonidine—glaucoma	0.00031	0.000874	CcSEcCtD
Tapentadol—Infection—Clonidine—glaucoma	0.000309	0.000872	CcSEcCtD
Tapentadol—Diarrhoea—Acetazolamide—glaucoma	0.000308	0.000868	CcSEcCtD
Tapentadol—Rash—Bimatoprost—glaucoma	0.000307	0.000867	CcSEcCtD
Tapentadol—Dermatitis—Bimatoprost—glaucoma	0.000307	0.000866	CcSEcCtD
Tapentadol—Shock—Clonidine—glaucoma	0.000306	0.000863	CcSEcCtD
Tapentadol—Connective tissue disorder—Timolol—glaucoma	0.000306	0.000863	CcSEcCtD
Tapentadol—Pruritus—Brimonidine—glaucoma	0.000305	0.000862	CcSEcCtD
Tapentadol—Headache—Bimatoprost—glaucoma	0.000305	0.000862	CcSEcCtD
Tapentadol—Nervous system disorder—Clonidine—glaucoma	0.000305	0.000861	CcSEcCtD
Tapentadol—Hypersensitivity—Dorzolamide—glaucoma	0.000304	0.000857	CcSEcCtD
Tapentadol—Tachycardia—Clonidine—glaucoma	0.000303	0.000856	CcSEcCtD
Tapentadol—Hypersensitivity—Travoprost—glaucoma	0.000302	0.000853	CcSEcCtD
Tapentadol—Skin disorder—Clonidine—glaucoma	0.000302	0.000852	CcSEcCtD
Tapentadol—Hyperhidrosis—Clonidine—glaucoma	0.000301	0.000848	CcSEcCtD
Tapentadol—Visual impairment—Timolol—glaucoma	0.0003	0.000847	CcSEcCtD
Tapentadol—Nausea—Apraclonidine—glaucoma	0.000298	0.000843	CcSEcCtD
Tapentadol—Hypersensitivity—Brinzolamide—glaucoma	0.000298	0.000842	CcSEcCtD
Tapentadol—Vertigo—Betaxolol—glaucoma	0.000298	0.000841	CcSEcCtD
Tapentadol—Syncope—Betaxolol—glaucoma	0.000297	0.000839	CcSEcCtD
Tapentadol—Dizziness—Acetazolamide—glaucoma	0.000297	0.000839	CcSEcCtD
Tapentadol—Asthenia—Dorzolamide—glaucoma	0.000296	0.000834	CcSEcCtD
Tapentadol—Asthenia—Travoprost—glaucoma	0.000294	0.000831	CcSEcCtD
Tapentadol—Palpitations—Betaxolol—glaucoma	0.000293	0.000827	CcSEcCtD
Tapentadol—Pruritus—Dorzolamide—glaucoma	0.000291	0.000823	CcSEcCtD
Tapentadol—Loss of consciousness—Betaxolol—glaucoma	0.000291	0.000823	CcSEcCtD
Tapentadol—Eye disorder—Timolol—glaucoma	0.000291	0.000821	CcSEcCtD
Tapentadol—Asthenia—Brinzolamide—glaucoma	0.000291	0.00082	CcSEcCtD
Tapentadol—Hypotension—Clonidine—glaucoma	0.00029	0.00082	CcSEcCtD
Tapentadol—Pruritus—Travoprost—glaucoma	0.00029	0.000819	CcSEcCtD
Tapentadol—Cough—Betaxolol—glaucoma	0.000289	0.000817	CcSEcCtD
Tapentadol—Nausea—Bimatoprost—glaucoma	0.000289	0.000817	CcSEcCtD
Tapentadol—Cardiac disorder—Timolol—glaucoma	0.000289	0.000815	CcSEcCtD
Tapentadol—Hypersensitivity—Pilocarpine—glaucoma	0.000287	0.00081	CcSEcCtD
Tapentadol—Pruritus—Brinzolamide—glaucoma	0.000287	0.000809	CcSEcCtD
Tapentadol—Vomiting—Acetazolamide—glaucoma	0.000286	0.000807	CcSEcCtD
Tapentadol—Dizziness—Brimonidine—glaucoma	0.000285	0.000805	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Clonidine—glaucoma	0.000283	0.0008	CcSEcCtD
Tapentadol—Angiopathy—Timolol—glaucoma	0.000282	0.000797	CcSEcCtD
Tapentadol—Arthralgia—Betaxolol—glaucoma	0.000282	0.000797	CcSEcCtD
Tapentadol—Diarrhoea—Dorzolamide—glaucoma	0.000282	0.000796	CcSEcCtD
Tapentadol—Headache—Acetazolamide—glaucoma	0.000282	0.000795	CcSEcCtD
Tapentadol—Anxiety—Betaxolol—glaucoma	0.000281	0.000794	CcSEcCtD
Tapentadol—Insomnia—Clonidine—glaucoma	0.000281	0.000794	CcSEcCtD
Tapentadol—Immune system disorder—Timolol—glaucoma	0.000281	0.000793	CcSEcCtD
Tapentadol—Diarrhoea—Travoprost—glaucoma	0.000281	0.000792	CcSEcCtD
Tapentadol—Mediastinal disorder—Timolol—glaucoma	0.00028	0.000792	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00028	0.000791	CcSEcCtD
Tapentadol—Asthenia—Pilocarpine—glaucoma	0.000279	0.000788	CcSEcCtD
Tapentadol—Paraesthesia—Clonidine—glaucoma	0.000279	0.000788	CcSEcCtD
Tapentadol—Dyspnoea—Clonidine—glaucoma	0.000277	0.000782	CcSEcCtD
Tapentadol—Diarrhoea—Brinzolamide—glaucoma	0.000277	0.000782	CcSEcCtD
Tapentadol—Somnolence—Clonidine—glaucoma	0.000276	0.00078	CcSEcCtD
Tapentadol—Dry mouth—Betaxolol—glaucoma	0.000276	0.000779	CcSEcCtD
Tapentadol—Pruritus—Pilocarpine—glaucoma	0.000275	0.000777	CcSEcCtD
Tapentadol—Confusional state—Betaxolol—glaucoma	0.000273	0.00077	CcSEcCtD
Tapentadol—Mental disorder—Timolol—glaucoma	0.000273	0.00077	CcSEcCtD
Tapentadol—Dizziness—Dorzolamide—glaucoma	0.000272	0.000769	CcSEcCtD
Tapentadol—Rash—Brimonidine—glaucoma	0.000272	0.000768	CcSEcCtD
Tapentadol—Dermatitis—Brimonidine—glaucoma	0.000272	0.000767	CcSEcCtD
Tapentadol—Dizziness—Travoprost—glaucoma	0.000271	0.000766	CcSEcCtD
Tapentadol—Malnutrition—Timolol—glaucoma	0.000271	0.000765	CcSEcCtD
Tapentadol—Oedema—Betaxolol—glaucoma	0.000271	0.000764	CcSEcCtD
Tapentadol—Headache—Brimonidine—glaucoma	0.00027	0.000763	CcSEcCtD
Tapentadol—Decreased appetite—Clonidine—glaucoma	0.00027	0.000763	CcSEcCtD
Tapentadol—Infection—Betaxolol—glaucoma	0.000269	0.000759	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Clonidine—glaucoma	0.000268	0.000758	CcSEcCtD
Tapentadol—Fatigue—Clonidine—glaucoma	0.000268	0.000757	CcSEcCtD
Tapentadol—Dizziness—Brinzolamide—glaucoma	0.000268	0.000756	CcSEcCtD
Tapentadol—Nausea—Acetazolamide—glaucoma	0.000267	0.000754	CcSEcCtD
Tapentadol—Diarrhoea—Pilocarpine—glaucoma	0.000266	0.000752	CcSEcCtD
Tapentadol—Shock—Betaxolol—glaucoma	0.000266	0.000752	CcSEcCtD
Tapentadol—Tension—Timolol—glaucoma	0.000266	0.00075	CcSEcCtD
Tapentadol—Constipation—Clonidine—glaucoma	0.000266	0.00075	CcSEcCtD
Tapentadol—Nervous system disorder—Betaxolol—glaucoma	0.000265	0.000749	CcSEcCtD
Tapentadol—Tachycardia—Betaxolol—glaucoma	0.000264	0.000746	CcSEcCtD
Tapentadol—Nervousness—Timolol—glaucoma	0.000263	0.000743	CcSEcCtD
Tapentadol—Skin disorder—Betaxolol—glaucoma	0.000263	0.000742	CcSEcCtD
Tapentadol—Vomiting—Dorzolamide—glaucoma	0.000262	0.000739	CcSEcCtD
Tapentadol—Hyperhidrosis—Betaxolol—glaucoma	0.000262	0.000739	CcSEcCtD
Tapentadol—Rash—Dorzolamide—glaucoma	0.00026	0.000733	CcSEcCtD
Tapentadol—Dermatitis—Dorzolamide—glaucoma	0.00026	0.000733	CcSEcCtD
Tapentadol—Rash—Travoprost—glaucoma	0.000259	0.00073	CcSEcCtD
Tapentadol—Dermatitis—Travoprost—glaucoma	0.000258	0.000729	CcSEcCtD
Tapentadol—Headache—Dorzolamide—glaucoma	0.000258	0.000729	CcSEcCtD
Tapentadol—Vomiting—Brinzolamide—glaucoma	0.000258	0.000727	CcSEcCtD
Tapentadol—Dizziness—Pilocarpine—glaucoma	0.000257	0.000727	CcSEcCtD
Tapentadol—Headache—Travoprost—glaucoma	0.000257	0.000725	CcSEcCtD
Tapentadol—Nausea—Brimonidine—glaucoma	0.000256	0.000723	CcSEcCtD
Tapentadol—Feeling abnormal—Clonidine—glaucoma	0.000256	0.000723	CcSEcCtD
Tapentadol—Rash—Brinzolamide—glaucoma	0.000255	0.000721	CcSEcCtD
Tapentadol—Vision blurred—Timolol—glaucoma	0.000255	0.000721	CcSEcCtD
Tapentadol—Dermatitis—Brinzolamide—glaucoma	0.000255	0.00072	CcSEcCtD
Tapentadol—Headache—Brinzolamide—glaucoma	0.000254	0.000716	CcSEcCtD
Tapentadol—Hypotension—Betaxolol—glaucoma	0.000253	0.000714	CcSEcCtD
Tapentadol—Angioedema—Timolol—glaucoma	0.000248	0.000699	CcSEcCtD
Tapentadol—Vomiting—Pilocarpine—glaucoma	0.000248	0.000699	CcSEcCtD
Tapentadol—Urticaria—Clonidine—glaucoma	0.000247	0.000697	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000247	0.000696	CcSEcCtD
Tapentadol—Rash—Pilocarpine—glaucoma	0.000245	0.000693	CcSEcCtD
Tapentadol—Dermatitis—Pilocarpine—glaucoma	0.000245	0.000692	CcSEcCtD
Tapentadol—Insomnia—Betaxolol—glaucoma	0.000245	0.000691	CcSEcCtD
Tapentadol—Nausea—Dorzolamide—glaucoma	0.000245	0.000691	CcSEcCtD
Tapentadol—Headache—Pilocarpine—glaucoma	0.000244	0.000688	CcSEcCtD
Tapentadol—Nausea—Travoprost—glaucoma	0.000244	0.000688	CcSEcCtD
Tapentadol—Vertigo—Timolol—glaucoma	0.000243	0.000687	CcSEcCtD
Tapentadol—Paraesthesia—Betaxolol—glaucoma	0.000243	0.000686	CcSEcCtD
Tapentadol—Syncope—Timolol—glaucoma	0.000243	0.000686	CcSEcCtD
Tapentadol—Dyspnoea—Betaxolol—glaucoma	0.000241	0.000681	CcSEcCtD
Tapentadol—Nausea—Brinzolamide—glaucoma	0.000241	0.000679	CcSEcCtD
Tapentadol—Palpitations—Timolol—glaucoma	0.000239	0.000676	CcSEcCtD
Tapentadol—Dyspepsia—Betaxolol—glaucoma	0.000238	0.000673	CcSEcCtD
Tapentadol—Loss of consciousness—Timolol—glaucoma	0.000238	0.000672	CcSEcCtD
Tapentadol—Cough—Timolol—glaucoma	0.000236	0.000667	CcSEcCtD
Tapentadol—Decreased appetite—Betaxolol—glaucoma	0.000235	0.000664	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Betaxolol—glaucoma	0.000234	0.00066	CcSEcCtD
Tapentadol—Fatigue—Betaxolol—glaucoma	0.000233	0.000659	CcSEcCtD
Tapentadol—Constipation—Betaxolol—glaucoma	0.000231	0.000653	CcSEcCtD
Tapentadol—Nausea—Pilocarpine—glaucoma	0.000231	0.000653	CcSEcCtD
Tapentadol—Arthralgia—Timolol—glaucoma	0.000231	0.000651	CcSEcCtD
Tapentadol—Anxiety—Timolol—glaucoma	0.00023	0.000649	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000229	0.000647	CcSEcCtD
Tapentadol—Hypersensitivity—Clonidine—glaucoma	0.000229	0.000647	CcSEcCtD
Tapentadol—Dry mouth—Timolol—glaucoma	0.000226	0.000637	CcSEcCtD
Tapentadol—Asthenia—Clonidine—glaucoma	0.000223	0.00063	CcSEcCtD
Tapentadol—Feeling abnormal—Betaxolol—glaucoma	0.000223	0.00063	CcSEcCtD
Tapentadol—Confusional state—Timolol—glaucoma	0.000223	0.000629	CcSEcCtD
Tapentadol—Anaphylactic shock—Timolol—glaucoma	0.000221	0.000624	CcSEcCtD
Tapentadol—Oedema—Timolol—glaucoma	0.000221	0.000624	CcSEcCtD
Tapentadol—Pruritus—Clonidine—glaucoma	0.00022	0.000621	CcSEcCtD
Tapentadol—Infection—Timolol—glaucoma	0.00022	0.00062	CcSEcCtD
Tapentadol—Shock—Timolol—glaucoma	0.000218	0.000614	CcSEcCtD
Tapentadol—Nervous system disorder—Timolol—glaucoma	0.000217	0.000612	CcSEcCtD
Tapentadol—Urticaria—Betaxolol—glaucoma	0.000215	0.000607	CcSEcCtD
Tapentadol—Skin disorder—Timolol—glaucoma	0.000215	0.000606	CcSEcCtD
Tapentadol—Hyperhidrosis—Timolol—glaucoma	0.000214	0.000603	CcSEcCtD
Tapentadol—Diarrhoea—Clonidine—glaucoma	0.000213	0.0006	CcSEcCtD
Tapentadol—Hypotension—Timolol—glaucoma	0.000207	0.000583	CcSEcCtD
Tapentadol—Dizziness—Clonidine—glaucoma	0.000206	0.00058	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Timolol—glaucoma	0.000201	0.000569	CcSEcCtD
Tapentadol—Insomnia—Timolol—glaucoma	0.0002	0.000565	CcSEcCtD
Tapentadol—Hypersensitivity—Betaxolol—glaucoma	0.000199	0.000563	CcSEcCtD
Tapentadol—Paraesthesia—Timolol—glaucoma	0.000199	0.00056	CcSEcCtD
Tapentadol—Vomiting—Clonidine—glaucoma	0.000198	0.000558	CcSEcCtD
Tapentadol—Dyspnoea—Timolol—glaucoma	0.000197	0.000556	CcSEcCtD
Tapentadol—Somnolence—Timolol—glaucoma	0.000197	0.000555	CcSEcCtD
Tapentadol—Rash—Clonidine—glaucoma	0.000196	0.000553	CcSEcCtD
Tapentadol—Dermatitis—Clonidine—glaucoma	0.000196	0.000553	CcSEcCtD
Tapentadol—Headache—Clonidine—glaucoma	0.000195	0.00055	CcSEcCtD
Tapentadol—Dyspepsia—Timolol—glaucoma	0.000195	0.000549	CcSEcCtD
Tapentadol—Asthenia—Betaxolol—glaucoma	0.000194	0.000548	CcSEcCtD
Tapentadol—Decreased appetite—Timolol—glaucoma	0.000192	0.000543	CcSEcCtD
Tapentadol—Pruritus—Betaxolol—glaucoma	0.000191	0.000541	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Timolol—glaucoma	0.000191	0.000539	CcSEcCtD
Tapentadol—Fatigue—Timolol—glaucoma	0.000191	0.000538	CcSEcCtD
Tapentadol—Diarrhoea—Betaxolol—glaucoma	0.000185	0.000523	CcSEcCtD
Tapentadol—Nausea—Clonidine—glaucoma	0.000185	0.000521	CcSEcCtD
Tapentadol—Feeling abnormal—Timolol—glaucoma	0.000182	0.000514	CcSEcCtD
Tapentadol—Dizziness—Betaxolol—glaucoma	0.000179	0.000505	CcSEcCtD
Tapentadol—Urticaria—Timolol—glaucoma	0.000176	0.000496	CcSEcCtD
Tapentadol—Vomiting—Betaxolol—glaucoma	0.000172	0.000486	CcSEcCtD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—NGF—glaucoma	0.000172	0.00249	CbGpPWpGaD
Tapentadol—UGT2B7—Metapathway biotransformation—GSTM1—glaucoma	0.000171	0.00249	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000171	0.00248	CbGpPWpGaD
Tapentadol—Rash—Betaxolol—glaucoma	0.000171	0.000482	CcSEcCtD
Tapentadol—Dermatitis—Betaxolol—glaucoma	0.00017	0.000481	CcSEcCtD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.00017	0.00247	CbGpPWpGaD
Tapentadol—Headache—Betaxolol—glaucoma	0.00017	0.000479	CcSEcCtD
Tapentadol—OPRD1—GPCR downstream signaling—OPN4—glaucoma	0.000168	0.00244	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—GSTM1—glaucoma	0.000168	0.00243	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000165	0.00239	CbGpPWpGaD
Tapentadol—Hypersensitivity—Timolol—glaucoma	0.000163	0.00046	CcSEcCtD
Tapentadol—UGT1A9—NRF2 pathway—GSTM1—glaucoma	0.000161	0.00234	CbGpPWpGaD
Tapentadol—Nausea—Betaxolol—glaucoma	0.000161	0.000454	CcSEcCtD
Tapentadol—Asthenia—Timolol—glaucoma	0.000159	0.000448	CcSEcCtD
Tapentadol—Pruritus—Timolol—glaucoma	0.000156	0.000442	CcSEcCtD
Tapentadol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000156	0.00227	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CA5A—glaucoma	0.000155	0.00225	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NARFL—glaucoma	0.000155	0.00225	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000154	0.00224	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—EDN1—glaucoma	0.000153	0.00221	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—OPN4—glaucoma	0.000152	0.00221	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—C3—glaucoma	0.000152	0.00221	CbGpPWpGaD
Tapentadol—Diarrhoea—Timolol—glaucoma	0.000151	0.000427	CcSEcCtD
Tapentadol—OPRD1—GPCR downstream signaling—PTGFR—glaucoma	0.000151	0.00219	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—OPN4—glaucoma	0.000147	0.00214	CbGpPWpGaD
Tapentadol—Dizziness—Timolol—glaucoma	0.000146	0.000413	CcSEcCtD
Tapentadol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000144	0.00209	CbGpPWpGaD
Tapentadol—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000142	0.00207	CbGpPWpGaD
Tapentadol—UGT1A9—Biological oxidations—GSTM1—glaucoma	0.000141	0.00205	CbGpPWpGaD
Tapentadol—Vomiting—Timolol—glaucoma	0.000141	0.000397	CcSEcCtD
Tapentadol—Rash—Timolol—glaucoma	0.000139	0.000394	CcSEcCtD
Tapentadol—Dermatitis—Timolol—glaucoma	0.000139	0.000393	CcSEcCtD
Tapentadol—UGT1A9—Metapathway biotransformation—GSTM1—glaucoma	0.000139	0.00202	CbGpPWpGaD
Tapentadol—Headache—Timolol—glaucoma	0.000139	0.000391	CcSEcCtD
Tapentadol—OPRD1—Signaling by GPCR—PTGFR—glaucoma	0.000137	0.00199	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—FAS—glaucoma	0.000135	0.00196	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—SMO—glaucoma	0.000135	0.00196	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—OPN4—glaucoma	0.000134	0.00194	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—C3—glaucoma	0.000133	0.00193	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PTGFR—glaucoma	0.000132	0.00192	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000132	0.00192	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000132	0.00191	CbGpPWpGaD
Tapentadol—Nausea—Timolol—glaucoma	0.000131	0.000371	CcSEcCtD
Tapentadol—OPRD1—Signaling Pathways—LRP12—glaucoma	0.00013	0.00188	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—EDN1—glaucoma	0.000129	0.00187	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—C3—glaucoma	0.000128	0.00186	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—OPN4—glaucoma	0.000124	0.0018	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PTGFR—glaucoma	0.00012	0.00175	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—SMO—glaucoma	0.000118	0.00172	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000117	0.00169	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LRP12—glaucoma	0.000114	0.00165	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—OPN4—glaucoma	0.000113	0.00164	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—TNF—glaucoma	0.000113	0.00164	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—C3—glaucoma	0.000113	0.00163	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—C3—glaucoma	0.000112	0.00163	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PTGFR—glaucoma	0.000112	0.00162	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—GSTT1—glaucoma	0.000104	0.00151	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000102	0.00149	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000102	0.00148	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PTGFR—glaucoma	0.000102	0.00148	CbGpPWpGaD
Tapentadol—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	0.0001	0.00146	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—SMO—glaucoma	9.99e-05	0.00145	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.69e-05	0.00141	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LRP12—glaucoma	9.62e-05	0.0014	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—GSTT1—glaucoma	9.58e-05	0.00139	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—C3—glaucoma	9.5e-05	0.00138	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—GSTT1—glaucoma	9.49e-05	0.00138	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CA1—glaucoma	9.33e-05	0.00135	CbGpPWpGaD
Tapentadol—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	9.16e-05	0.00133	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CTSA—glaucoma	9.04e-05	0.00131	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—OPN4—glaucoma	9e-05	0.00131	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	8.94e-05	0.0013	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—EDN1—glaucoma	8.89e-05	0.00129	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	8.65e-05	0.00126	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CA2—glaucoma	8.53e-05	0.00124	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HEYL—glaucoma	8.37e-05	0.00121	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—CYP1B1—glaucoma	8.3e-05	0.0012	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	8.21e-05	0.00119	CbGpPWpGaD
Tapentadol—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	8.18e-05	0.00119	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTGFR—glaucoma	8.1e-05	0.00118	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—OPN4—glaucoma	7.89e-05	0.00115	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—EDN1—glaucoma	7.79e-05	0.00113	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—C3—glaucoma	7.76e-05	0.00113	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.75e-05	0.00113	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—CYP1B1—glaucoma	7.63e-05	0.00111	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CA1—glaucoma	7.58e-05	0.0011	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—CYP1B1—glaucoma	7.56e-05	0.0011	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	7.55e-05	0.0011	CbGpPWpGaD
Tapentadol—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	7.53e-05	0.00109	CbGpPWpGaD
Tapentadol—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	7.46e-05	0.00108	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CTSA—glaucoma	7.34e-05	0.00107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HEYL—glaucoma	7.34e-05	0.00106	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CA5A—glaucoma	7.3e-05	0.00106	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NARFL—glaucoma	7.3e-05	0.00106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTGFR—glaucoma	7.11e-05	0.00103	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	7.07e-05	0.00103	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	7.04e-05	0.00102	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CA2—glaucoma	6.94e-05	0.00101	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—SMO—glaucoma	6.92e-05	0.001	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—C3—glaucoma	6.81e-05	0.000988	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.78e-05	0.000984	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.78e-05	0.000984	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NARFL—glaucoma	6.71e-05	0.000974	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CA5A—glaucoma	6.71e-05	0.000974	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—OPN4—glaucoma	6.67e-05	0.000968	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NARFL—glaucoma	6.65e-05	0.000966	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CA5A—glaucoma	6.65e-05	0.000966	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—GSTM1—glaucoma	6.63e-05	0.000963	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—EDN1—glaucoma	6.59e-05	0.000956	CbGpPWpGaD
Tapentadol—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	6.54e-05	0.00095	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RPTOR—glaucoma	6.34e-05	0.00092	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HEYL—glaucoma	6.2e-05	0.0009	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NCK2—glaucoma	6.14e-05	0.000891	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—GSTM1—glaucoma	6.1e-05	0.000886	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—SMO—glaucoma	6.06e-05	0.00088	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—GSTM1—glaucoma	6.05e-05	0.000878	CbGpPWpGaD
Tapentadol—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	6.02e-05	0.000873	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TXN—glaucoma	6.01e-05	0.000873	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTGFR—glaucoma	6e-05	0.000872	CbGpPWpGaD
Tapentadol—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.96e-05	0.000866	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—C3—glaucoma	5.75e-05	0.000835	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RPTOR—glaucoma	5.56e-05	0.000807	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NCK2—glaucoma	5.38e-05	0.000782	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HDAC9—glaucoma	5.22e-05	0.000758	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—SMO—glaucoma	5.13e-05	0.000744	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—TP53—glaucoma	5.06e-05	0.000735	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—EDN1—glaucoma	5.02e-05	0.000729	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TXN—glaucoma	4.89e-05	0.000709	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RPTOR—glaucoma	4.7e-05	0.000682	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GSTT1—glaucoma	4.66e-05	0.000677	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HDAC9—glaucoma	4.58e-05	0.000665	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—EDN1—glaucoma	4.56e-05	0.000662	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NCK2—glaucoma	4.55e-05	0.000661	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.46e-05	0.000647	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.42e-05	0.000641	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—EDN1—glaucoma	4.4e-05	0.000639	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—C3—glaucoma	4.39e-05	0.000637	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SMO—glaucoma	4.09e-05	0.000593	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—EDN1—glaucoma	4e-05	0.00058	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—C3—glaucoma	3.98e-05	0.000578	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HDAC9—glaucoma	3.87e-05	0.000562	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—C3—glaucoma	3.85e-05	0.000558	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTT1—glaucoma	3.79e-05	0.00055	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NTRK2—glaucoma	3.74e-05	0.000542	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—EDN1—glaucoma	3.72e-05	0.00054	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CYP1B1—glaucoma	3.72e-05	0.000539	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ABCA1—glaucoma	3.72e-05	0.000539	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SMO—glaucoma	3.58e-05	0.00052	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CA1—glaucoma	3.56e-05	0.000517	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—C3—glaucoma	3.49e-05	0.000507	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CTSA—glaucoma	3.45e-05	0.000501	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EDN1—glaucoma	3.38e-05	0.000491	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CA1—glaucoma	3.28e-05	0.000476	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NTRK2—glaucoma	3.28e-05	0.000476	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CA2—glaucoma	3.26e-05	0.000473	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—C3—glaucoma	3.25e-05	0.000472	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CA1—glaucoma	3.25e-05	0.000472	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NGFR—glaucoma	3.21e-05	0.000465	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.19e-05	0.000462	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.19e-05	0.000462	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CTSA—glaucoma	3.17e-05	0.000461	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CTSA—glaucoma	3.15e-05	0.000457	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.06e-05	0.000443	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NTRK1—glaucoma	3.05e-05	0.000442	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SMO—glaucoma	3.03e-05	0.00044	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCA1—glaucoma	3.02e-05	0.000438	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CYP1B1—glaucoma	3.02e-05	0.000438	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CA2—glaucoma	3e-05	0.000435	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CA2—glaucoma	2.97e-05	0.000431	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GSTM1—glaucoma	2.97e-05	0.000431	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—C3—glaucoma	2.95e-05	0.000429	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.9e-05	0.000422	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.9e-05	0.000422	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NGFR—glaucoma	2.81e-05	0.000408	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDKN2B—glaucoma	2.81e-05	0.000407	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK2—glaucoma	2.77e-05	0.000402	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EDN1—glaucoma	2.69e-05	0.000391	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NTRK1—glaucoma	2.67e-05	0.000388	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—glaucoma	2.62e-05	0.000381	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NGF—glaucoma	2.48e-05	0.000359	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDKN2B—glaucoma	2.46e-05	0.000357	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOE—glaucoma	2.44e-05	0.000355	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CAV1—glaucoma	2.42e-05	0.000351	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTM1—glaucoma	2.41e-05	0.00035	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NGFR—glaucoma	2.38e-05	0.000345	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EDN1—glaucoma	2.36e-05	0.000343	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—C3—glaucoma	2.35e-05	0.000342	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TXN—glaucoma	2.3e-05	0.000333	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK1—glaucoma	2.26e-05	0.000328	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOE—glaucoma	2.19e-05	0.000318	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NGF—glaucoma	2.17e-05	0.000315	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CAV1—glaucoma	2.17e-05	0.000315	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—glaucoma	2.13e-05	0.00031	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TXN—glaucoma	2.11e-05	0.000307	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.1e-05	0.000304	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TXN—glaucoma	2.09e-05	0.000304	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN2B—glaucoma	2.08e-05	0.000302	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.08e-05	0.000301	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FN1—glaucoma	2.07e-05	0.0003	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—C3—glaucoma	2.06e-05	0.0003	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—BAD—glaucoma	2.04e-05	0.000296	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EDN1—glaucoma	2e-05	0.00029	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOE—glaucoma	1.99e-05	0.000288	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CAV1—glaucoma	1.97e-05	0.000286	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOE—glaucoma	1.92e-05	0.000279	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.91e-05	0.000277	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CAV1—glaucoma	1.9e-05	0.000276	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.89e-05	0.000275	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NGF—glaucoma	1.83e-05	0.000266	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NOS3—glaucoma	1.83e-05	0.000266	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FN1—glaucoma	1.81e-05	0.000263	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—BAD—glaucoma	1.79e-05	0.00026	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTT1—glaucoma	1.78e-05	0.000258	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—C3—glaucoma	1.74e-05	0.000253	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—glaucoma	1.67e-05	0.000243	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—glaucoma	1.64e-05	0.000238	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTT1—glaucoma	1.64e-05	0.000238	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTT1—glaucoma	1.62e-05	0.000236	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—glaucoma	1.62e-05	0.000236	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CAV1—glaucoma	1.61e-05	0.000233	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FN1—glaucoma	1.53e-05	0.000222	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—BAD—glaucoma	1.51e-05	0.00022	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—glaucoma	1.49e-05	0.000216	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—glaucoma	1.44e-05	0.000209	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.44e-05	0.000208	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDKN1B—glaucoma	1.42e-05	0.000206	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCA1—glaucoma	1.42e-05	0.000206	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CYP1B1—glaucoma	1.42e-05	0.000206	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—glaucoma	1.36e-05	0.000197	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—glaucoma	1.32e-05	0.000191	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.31e-05	0.00019	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCA1—glaucoma	1.31e-05	0.000189	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CYP1B1—glaucoma	1.31e-05	0.000189	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCA1—glaucoma	1.29e-05	0.000188	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CYP1B1—glaucoma	1.29e-05	0.000188	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDKN1B—glaucoma	1.25e-05	0.000181	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—glaucoma	1.22e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—glaucoma	1.18e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—glaucoma	1.15e-05	0.000168	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTM1—glaucoma	1.13e-05	0.000165	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN1B—glaucoma	1.05e-05	0.000153	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTM1—glaucoma	1.04e-05	0.000151	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—glaucoma	1.04e-05	0.000151	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTM1—glaucoma	1.03e-05	0.00015	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—glaucoma	1e-05	0.000146	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—glaucoma	9.76e-06	0.000142	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—glaucoma	9.33e-06	0.000135	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAV1—glaucoma	9.25e-06	0.000134	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—glaucoma	9.22e-06	0.000134	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—glaucoma	9.14e-06	0.000133	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—glaucoma	8.93e-06	0.00013	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—glaucoma	8.76e-06	0.000127	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—glaucoma	8.58e-06	0.000125	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—glaucoma	8.51e-06	0.000124	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAV1—glaucoma	8.5e-06	0.000123	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAV1—glaucoma	8.43e-06	0.000122	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—glaucoma	7.83e-06	0.000114	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—glaucoma	6.99e-06	0.000101	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—glaucoma	6.62e-06	9.61e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—glaucoma	6.43e-06	9.33e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—glaucoma	6.39e-06	9.28e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—glaucoma	6.38e-06	9.25e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—glaucoma	5.88e-06	8.54e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—glaucoma	5.83e-06	8.46e-05	CbGpPWpGaD
